Scope Fluidics Appoints a World-Class Advisory Board to Accelerate the continued Dynamic Development of the Company


Scope Fluidics is pleased to announce the appointment of its Advisory Board comprised of world-class specialists in diagnostics, microbiology, and bacterial infections, as well as experienced and successful entrepreneurs. These advisory board members will support Scope Fluidics in its continued dynamic development.

The Advisory Board was joined by:

– Dr Vincent Linder – Founder of Claros Diagnostics – a tech start-up spin-out of the Harvard University; it was sold to an investor for over 50 million USD. Dr Linder has also authored over 300 patents related to microfluidic and point-of-care techniques.

– Dr David Wareham, a world-class clinical microbiologist from the renowned Queen Mary University of London and London’s largest microbiological laboratory. Dr Wareham has a vast experience in diagnostics, treatment, and scientific research on bacterial infections.

– Sarai Kemp, an Israeli specialist in development of biotechnological and life science start-ups, has many years of experience in the acquisition of financing, commercialization, and sale of projects, as well as leading start-ups in an international environment.

The Advisory Board’s task will be, in particular, to provide Scope’s Management Board with opinions and recommendations on current and future biotechnological projects developed by Scope Fluidics. Moreover, members of the Advisory Board will support the company with their contacts, including global manufacturers of med tech solutions, laboratories, clinics, and financial institutions which support all types of projects. The Advisory Board will also supervise the development of Scope Fluidics’ strategy, advise, and help the Management Board regarding new solutions and technologies on the market and in the scientific research area.

“The appointment of the Advisory Board is a major step in the development of our projects. Our projects have attracted interest of recognized international authorities. The Advisory Board will help us determine our strategy in order to reinforce our ability to identify the sectors of growth and transfer of specialised knowledge. It is of crucial importance to us that the Advisory Board was joined by such renowned persons. It not only influences our image – since it proves that those specialists believe in our business venture – but also provides us with tangible benefits, namely, rapid transfer of know-how form the most precious sources available. We are convinced that their involvement will positively affect the implementation of Company’s strategic plans”, says Prof. Piotr Garstecki, co-founder, key-shareholder and CEO of Scope Fluidics.